GW-870086

Star0

DB12322InvestigationalSmall molecule

GW870086X has been investigated for the treatment of ASTHMA.

Mechanism: Pharmacologically active on Glucocorticoid receptor
Curator reviewed
Formula / weight: C₃₁H₃₉F₂NO₆ · 559.651 g/mol (avg)
Code names: GW870086 · GW870086X

Resolves to

Compound

UNIIO891A2A3ZUCAS827319-43-7PubChem11376392

Structure

InChIKeyWUBKGTSFJSEIEM-NSHBDUGJSA-NSMILESC[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1C(C)(C)C1(C)C)C(=O)OCC#N

Targets

P04150NR3C1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with GW-870086, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account